Cleveland Diagnostics Names Valerie Dixon CFO as IsoPSA Commercialization Expands

Tuesday, August 25, 2026Sobeida DiloneView original
Cleveland Diagnostics Names Valerie Dixon CFO as IsoPSA Commercialization Expands

Cleveland Diagnostics has appointed Valerie Dixon as Chief Financial Officer, adding a healthcare investment banking and strategic finance executive as... Read More

The post Cleveland Diagnostics Names Valerie Dixon CFO as IsoPSA Commercialization Expands appeared first on citybiz.